Paxlovid in COVID-19 Vaccinated patients

CEimpact Podcast

Nội dung được cung cấp bởi CEimpact. Tất cả nội dung podcast bao gồm các tập, đồ họa và mô tả podcast đều được CEimpact hoặc đối tác nền tảng podcast của họ tải lên và cung cấp trực tiếp. Nếu bạn cho rằng ai đó đang sử dụng tác phẩm có bản quyền của bạn mà không có sự cho phép của bạn, bạn có thể làm theo quy trình được nêu ở đây https://vi.player.fm/legal.

2M ago 26:21

MP3•Trang chủ episode

Join us as we explore new trial data examing Paxlovid's effectiveness in high-risk, vaccinated patients.
The GameChanger
Significantly high risk patients are still at risk from active Covid-19 infection. A new trial looks at Paxlovid use in high-risk, vaccincated patients.
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Reference
New England Journal of Medicine Article
Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss EPIC SR study findings.
2. Describe benefits of Paxlovid for specific patient groups based on trial data.
0.05 CEU/0.5 Hr
UAN: 0107-0000-24-172-H01-P
Initial release date: 05/13/2024
Expiration date: 05/13/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Chương

1. Paxlovid in COVID-19 Vaccinated patients (00:00:00)

2. COVID Treatment Update and Study Results (00:00:08)

3. Effectiveness of Paxlovid for COVID-19 (00:12:46)

284 tập

#Science #Higher Education #Pharmacy #Fitness #Medicine #CPE #Pharmacology #Geoff Wall #Pharmacotherapy #Podcasting Education #CEimpact #Precept2Practice #Level #GameChangers #CME